Present Status Of Thrombolytic Therapy For Acute Limb Ischemia: Safety, Efficacy And What Adjuncts May Be Helpful

New York, NY: Kenneth Ouriel, MD
Professor of Surgery, Ohio State University
Chairman, Department of Vascular Surgery, The Cleveland Clinic Foundation
9Cleveland, Ohio)will lecture on acute limb ischema, November 21.

Acute limb ischemia threatens both the patient's limb and life. Initial use of thrombolytic therapy allows one to defer the more invasive modalities of endovascular or open surgical repair until the patient can be better prepared for a major intervention. Furthermore, there is some evidence to confirm the impression that a less invasive intervention is better tolerated in this very ill group of patients who develop acute limb ischemia. Today, many centers employ intra-arterial thrombolytic therapy as the initial intervention, infusing thrombolytic agents directly into the occluding thrombus. Agents such as urokinase, alteplase and reteplase provide a less invasive means of restoring adequate arterial perfusion, addressing and unmasking the culprit lesion responsible for the occlusion.

Journalists, medical writers and reporters will have the opportunity to interview Dr. Villaviciencio. Information regarding press guidelines and registration is available at www.veithpress.org.

In addition, at this year’s VEITHsymposium™, an issue of historical interest and clinical importance is the fight over specialty status for vascular surgery. The unique and specialized skills and competencies required for vascular disease management and intervention have evolved rapidly over the past decade and now define and require a separate specialty. However, this evolutionary process is “strongly opposed” by The American Board of Surgery.

At VEITHsymposium™, ther featured vascular topics will include the outcomes of a recent study using an innovative endovascular graft system to treat ruptured aortoiliac aneurysms, and the role and efficacy of protection devices used for carotid artery stenting. Pharmacological treatments for the reversal of stroke, lipid and fibrinogen management, information about erectile dysfunction, new developments in dialysis access management and many more topics will be addressed. Live case presentations via satellite will be included throughout the 4-day conference. Journalists, medical writers and reporters can review a select choice of interesting and current vascular surgery topics, as well as information regarding access to interviews, press guidelines and registration at www.veithpress.org.

About VEITHsymposium™: For nearly three decades, VEITHsymposium™ has been the epicenter of physician education for the global vascular community. This international congress attracts over 1500 thought leaders in the field. More than 150 international clinician/educators present the latest topics, advances and data and then validate concepts through the dynamic interactive faculty/audience exchange that ends each session. VEITHsymposium™ is sponsored by Montefiore Medical Center (Bronx, NY). CME credit issued by Albert Einstein College of Medicine (Bronx, NY).




This article courtesy of http://www.cosmeticsreviews.net/.
You may freely reprint this article on your website or in
your newsletter provided this courtesy notice and the author
name and URL remain intact.

Related articles